Copyright © 2016
Aridis Pharmaceuticals, Inc.
5941 Optical Court, San Jose, CA 95138
Financial Conflict of Interest Policy
In compliance with federal regulations Aridis Pharmaceuticals requires Principal Investigators and other key personnel on a sponsored project to disclose a list of Significant Financial Interests (and those of his/her spouse and dependent children) that could be reasonably expected to bias the design, conduct, or reporting of the project. PIs, Co-
NEW federal regulations regarding financial conflict of interest (FCOI) have been issued by the Department of Health and Human Services and went into effect August 24, 2012.
The new regulations can be found here: http://grants.nih.gov/grants/policy/coi/fcoi_final_rule.pdf
The Aridis Financial Conflict of Interest Policy can be found here : Aridis FCOI Research Policy 2011.pdf (Available to public)
Aridis FCOI Disclosure Form can be found here: Aridis FCOI_Disclosure Form.pdf (Available to Aridis employees)
NIH Conflict of Interest Tutorial
Investigators are required to complete mandatory training before engaging in research funding by PHS. NIH has developed a web-
For more information, visit the following links:
42 CFR Part 50, 45 CFR Part 94 http://grants.nih.gov/grants/policy/coi/fcoi_final_rule.pdf
NIH FCOI FAQs http://grants.nih.gov/grants/policy/coi/coi_faqs.htm
NIH FCOI Tutorial http://grants.nih.gov/grants/policy/coi/tutorial2011/fcoi.htm
If you have any remaining questions about the Financial Conflict of Interest Policy or regarding completing the FCOI forms, please contact the designated Sponsored Programs Official.
Breakthrough Therapies for
Antibiotic Resistant Infections